www.xenios-ag.com Open in urlscan Pro
81.169.218.109  Public Scan

Submitted URL: http://i-cor.com/
Effective URL: https://www.xenios-ag.com/
Submission: On December 19 via api from US — Scanned from DE

Form analysis 3 forms found in the DOM

<form><span class="fieldset">
    <p><input type="checkbox" value="check" id="chkMain" checked="checked" class="legacy-group-status optanon-status-checkbox"><label for="chkMain">Active</label></p>
  </span></form>

GET https://www.xenios-ag.com/

<form role="search" method="get" id="searchform-sidenav" class="searchform" action="https://www.xenios-ag.com/">
  <div class="search-icon"></div>
  <input type="text" value="" name="s" id="s-sidebar">
  <input type="submit" id="search-sidebar-submit" value="Search" class="submit-btn">
</form>

GET https://www.xenios-ag.com/

<form role="search" method="get" id="searchform-footer" class="searchform" action="https://www.xenios-ag.com/">
  <div class="search-icon"></div>
  <input type="text" value="" name="s" id="s-footer">
  <input type="submit" id="search-footer-submit" value="Search" class="submit-btn">
</form>

Text Content

Cookie Notice

We use cookies to personalise content and ads, to provide social media features
and to analyse our traffic. We also share information about your use of our site
with our social media, advertising and analytics partners. Disclaimer


Close
Accept Cookies
Cookie Settings


 * Your Privacy

 * Strictly Necessary Cookies

 * Functional Cookies

 * Targeting Cookies

 * More Information

Privacy Preference Centre

Active

Always Active



Save Settings

Allow All


 * Xenios Platform
 * icor
 * Novalung
 * Medos
 * Pediatrics
 * Heart & Lung Campus
 * All


 * 
   Company
   * Career
   * News & Events
 * Xenios Platform
 * icor
 * 
   Novalung
   * Therapy
   * Product Overview
 * 
   Medos
   * Therapy
   * Product Overview
 * Pediatric patients
 * Xenios Campus
 * 
   Service & Contact
   * Clinical Support
   * Media Center
   * IFU
   * SVHC
   * Newsletter

 * Contact
 * Newsletter

 * CREATING A FUTURE WORTH LIVING.
   FOR PATIENTS. WORLDWIDE. EVERY DAY.
   
   Learn more


 * NOVALUNG
   SOLUTIONS FOR
   LUNG FAILURE
   
   Learn more


 * HERE FOR YOU.
   OUR CLINICAL
   SUPPORT
   
   Learn more


 * CAMPUS
   LEARNING WITH
   XENIOS
   
   Learn more





HEART AND LUNG THERAPIES

At Xenios, a Fresenius Medical Care company, we offer treatments for patients
suffering from cardiac and/or pulmonary failure. Based on a holistic
understanding of human physiology, we develop intelligent technological
solutions that can be vital for the survival of critically ill patients.

We offer solutions that combine both cardiac and pulmonary support on one single
technological platform. It supports the gas exchange in the lungs and the
cardiovascular system to keep patients alive. The physician thus gains more
vital treatment time during diagnosis and therapy.

Xenios is part of Fresenius Medical Care, the world’s leading provider of
products and services for people with renal diseases. We are complementing
Fresenius Medical Care’s product portfolio in the field of intensive care and
are continuing to shape the future of extracorporeal multi-organ support.

In our daily work, we share a passion for helping people. For patients.
Worldwide. Every day.

More about Xenios
Time to Heal - Novalung ECMO therapy




HEART THERAPIES

Medos is your partner experienced in cardiopulmonary solutions for more than 30
years: highly skilled employees and high-quality manufacturing, for the benefit
of cardiac surgeons, perfusionists and patients.

More about Medos


SYNCHRONIZED CARDIAC SUPPORT

Synchronized Cardiac Support is a new mechanical circulatory support method that
adapts to the patient’s heart rhythm.
Pulsatility is closer to human physiology than continuous flow. The therapeutic
goals are myocardial recovery and adequate organ perfusion.

More about icor


LUNG THERAPIES

Novalung therapy allows to mitigate, prevent or replace mechanical ventilation
by extracorporeal gas exchange. It enables caregivers to give the lung time to
heal and change the therapy environment in the ICU – from CO2 removal to full
oxygenation.

More about Novalung



BY
YOUR
SIDE




CLINICAL SUPPORT

Our international clinical support team accompanies the clinical application of
all Fresenius Medical Care Heart & Lung products.

These specialists, trained in intensive care, provide trainings on-site in
hospitals or online, e.g. for initial applications of our products.

Learn more



CAMPUS
LEARNING WITH XENIOS

LOOKING FOR FURTHER THERAPY- AND XENIOS PRODUCT INFORMATION?

Join our Heart & Lung Campus to explore various eLearnings, for example expert
interviews, best-practice-cases, medical knowledge, hands-on-tutorials and
priming instructions.

On demand, 24 hours a day, 7 days a week – whenever you need it.

Go to Heart & Lung Campus

NEWS

NEWS


XENIOS AG RECEIVES APPROVAL IN CHINA FOR ECMO DEVICES

13. July 2021

Xenios AG, a Fresenius Medical Care company, has received approval from the
National Medical Products Administration (NMPA) in China for the Xenios console
and patient kits for ECMO therapy. In early May, Xenios AG, a Fresenius Medical
Care company, received approval for two patient kits in China. It follows NMPA’s
...

Read full article


NEWS


EUROELSO 2021 VIRTUAL CONGRESS

28. April 2021

Meet Fresenius Medical Care Heart & Lung (Xenios) at EuroELSO 2021 and join our
symposium! In our virtual ICU, you will learn about our products and therapies
directly on a VV ECMO patient case. Talk to our experts via text chat and ask
all your questions. Also, join us for our ...

Read full article



CHANGES IN THE MANAGEMENT BOARD OF XENIOS AG

31. March 2021

The Management Board of Xenios AG, the Heart & Lung Business Unit of Fresenius
Medical Care, has been restructured. Effective January 31, 2021, the previous
Chair of the Executive Board, Dr. Andreas Terpin, has left the company. The new
senior trio on the Management Board will continue Fresenius Medical ...

Read full article



EVENTS


08. NOVEMBER – 31. JANUARY
UPCOMING EVENTS WILL BE DISPLAYED HERE

Stay up to date for 2022!



Go to Events




XENIOS AG
Im Zukunftspark 1
74076 Heilbronn, Germany
E-Mail: info@xenios-ag.com
Phone: +49 7131 2706 0
Fax: +49 7131 2706 299

Notice
Not all products and services are cleared or available for sale in all
countries.

Please check your country-specific regulations.

 * Service & Contact
 * Clinical Support
 * Newsletter

A Fresenius Medical Care Company
End of 2016, Xenios became a part of Fresenius Medical Care, the world’s leading
provider of products and services for people with chronic kidney failure.
www.freseniusmedicalcare.com

Find us on

 * Youtube
 * LinkedIn

 * Compliance

 * Legal Notice
 * TERMS AND CONDITIONS
 * Privacy Policy
 * SVHC
 * IFU

Info

Not all products or services presented on this website are cleared or available
for sale in all countries. For further information on country-specific
regulations, please contact your local Xenios AG representative.

Also, the information on this website is not intended for an audience within the
USA. If your are from the USA, please visit the corresponding Fresenius Medical
Care website here

Accepted and Confirmed
+